I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 7 studies | 24% ± 6% | |
| CD4-positive, alpha-beta T cell | 5 studies | 20% ± 4% | |
| endothelial cell | 5 studies | 27% ± 10% | |
| glutamatergic neuron | 5 studies | 43% ± 21% | |
| retina horizontal cell | 5 studies | 26% ± 4% | |
| astrocyte | 5 studies | 23% ± 8% | |
| effector memory CD8-positive, alpha-beta T cell | 4 studies | 20% ± 4% | |
| epithelial cell | 4 studies | 30% ± 4% | |
| GABAergic neuron | 4 studies | 41% ± 15% | |
| natural killer cell | 4 studies | 18% ± 1% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 20% ± 2% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 20% ± 1% | |
| T follicular helper cell | 3 studies | 15% ± 0% | |
| CD8-positive, alpha-beta T cell | 3 studies | 18% ± 2% | |
| T cell | 3 studies | 21% ± 3% | |
| endothelial cell of lymphatic vessel | 3 studies | 20% ± 3% | |
| lymphocyte | 3 studies | 30% ± 8% |
